DR. MICHAEL DAVID TROTTER M.D. NPI 1992779599

NPI Information

  • NPI: 1992779599
  • Provider Name: DR. MICHAEL DAVID TROTTER, M.D.
  • Classification: Urology - 208800000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1111 W 34TH ST
    SUITE 210
    AUSTIN, TX
    ZIP 78705
  • Phone: (512) 451-7935

Map and Directions

Get Directions

NPI Details

DR. Michael David Trotter, M.D. is an urology in Austin, TX with 25 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Michael David Trotter, M.D. NPI is 1992779599. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Graduation Year:2000

The provider's business location address is:

1111 W 34TH ST
SUITE 210
AUSTIN, TX
ZIP 78705-900
Phone: (512) 451-7935
Fax: (512) 451-7965

The NPI 1992779599 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
  • Automated urinalysis test (HCPCS:81003)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
  • Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
  • Placement of hormone pellet under skin (HCPCS:11980)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
  • Simple bladder irrigation and/or instillation (HCPCS:51700)
  • Ultrasound scan of pelvic region through rectum (HCPCS:76872)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Electronic assessment of bladder emptying (HCPCS:51741)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
  • Other procedure on male genital system (HCPCS:55899)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
  • Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
  • Biopsy of prostate gland (HCPCS:55700)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Imaging guidance for procedure, 60 minutes or less (HCPCS:76000)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Tissue marker, implantable, any type, each (HCPCS:A4648)
  • Injection of biodegradable material next to prostate (HCPCS:55874)
  • Placement of device in prostate for radiation therapy (HCPCS:55876)
  • Ultrasonic guidance for needle placement (HCPCS:76942)
  • Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 2/13/2006 and was last updated on 11/29/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1208800000XUrologyM0294TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1I36987MEDICARE UPINTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.